Menderes Akdag's most recent trade in Petmed Express, Inc. was a trade of 60,000 COMMON STOCK done at an average price of $45.5 . Disclosure was reported to the exchange on Jan. 27, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Petmed Express, Inc. | Menderes Akdag | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 45.50 per share. | 27 Jan 2021 | 60,000 | 337,800 (1%) | 0% | 45.5 | 2,730,000 | COMMON STOCK |
Petmed Express, Inc. | Menderes Akdag | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 31.20 per share. | 31 Jul 2020 | 37,800 | 397,800 (1%) | 0% | 31.2 | 1,179,360 | Common Stock |
Petmed Express, Inc. | Menderes Akdag | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 41.00 per share. | 16 Jul 2020 | 30,000 | 360,000 (1%) | 0% | 41 | 1,230,000 | Common Stock |
Petmed Express, Inc. | Menderes Akdag | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 31.25 per share. | 07 Apr 2020 | 20,000 | 390,000 (1%) | 0% | 31.3 | 625,000 | Common Stock |
Petmed Express, Inc. | Menderes Akdag | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 30.25 per share. | 03 Apr 2020 | 20,000 | 410,000 (2%) | 0% | 30.3 | 605,000 | Common Stock |
Petmed Express, Inc. | Menderes Akdag | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 29.50 per share. | 03 Apr 2020 | 10,000 | 430,000 (2%) | 0% | 29.5 | 295,000 | Common Stock |